ABPI

Protesting against health inequalities
#ABPI #NHS #UK government #US government

UK-US trade deal good news for UK life sciences, ABPI says 

The UK-US trade agreement is good news for NHS patients and will support the UK life sciences industry, the Association of the British Pharmaceutical Industry (ABPI) says.  The agreement will ensure that UK pharmaceutical exports to the US continue to face 0% tariffs for three years. In… Read More

#News

Subcutaneous injection
#ABPI #Clinical trial #UK #UK government

Decline in trial recruitment denying patients, ABPI warns 

The decline in commercial clinical trial recruitment is denying patients participation in cutting-edge research, the Association of the British Pharmaceutical Industry (ABPI) has warned.  According to the ABPI’s annual clinical trials report, the number of patients recruited into UK industry clinical trials fell by 25% between 2022/23… Read More

#News

UK and US flags
#ABPI #National Institute for Health and Care Excellence (NICE) #Pharmaceutical industry #UK government

UK-US pharmaceuticals deal supports UK life sciences

A trade deal has been agreed between the UK and the US, which the governments says will secure and expand access to drugs, safeguard the medicines supply chain, and “drive crucial investment while supporting UK patients and industries”.   The deal – part of the UK-US Economic Prosperity Deal – sees the… Read More

#Business & Investment #News #Trending News

#ABPI #ALS #Animal models #Cancer research #Covid-19 #Investment #Life sciences #MHRA #MND #mRNA-based vaccines

DDW Highlights: 18 November 2025

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, groundbreaking research showed the Covid-19 mRNA vaccine could boost cancer response. Elsewhere,… Read More

#Podcasts

#ABPI #ALS #Animal models #Cancer research #Covid-19 #Investment #Life sciences #MHRA #MND #mRNA-based vaccines

This week in Drug Discovery (10 – 14 November) 

News round-up for 10 – 14 November by Bruno Quinney, Content Team at DDW.  This week’s top story comes from groundbreaking research showing the Covid-19 mRNA vaccine boosts the immune system’s cancer response. The theme of UK investment dominates other headlines, while a report shows an effective… Read More

#News

Female scientists working in a lab
#ABPI #Biopharmaceuticals #Collaboration #Pharmaceutical industry

Industry-academic collaborations vital for UK pharma workforce

A surge in apprenticeships, placements, and global research collaborations is strengthening the UK’s pharmaceutical workforce.  This is a summary of the key findings from the latest Industry and Academic Links Survey from the Association of the British Pharmaceutical Industry (ABPI).  As National Apprenticeship Week (10-14 February) begins, new figures highlight… Read More

#Business & Investment #News

UK on global map
#ABPI #Clinical trials #Life sciences #UK

UK starts to rebuild global position for industry clinical trials

A new report finds the UK’s global rankings for industry clinical trial delivery are improving.  However, further challenges must be overcome if the UK is to fight off fierce international competition to attract lucrative life science research.  In its annual report on the health of UK industry clinical trials, the… Read More

#Business & Investment #News #Trends & Analysis

Downing Street, London, UK
#ABPI #Association of the British Pharmaceutical Industry #Life sciences #NHS #The King's Fund #UK government

Strong leadership needed for UK life sciences industry success

Health and care researchers at The King’s Fund are calling for the UK government and national NHS leaders to play a greater role in developing guidance and providing leadership of health service partnerships with the life sciences industry.   The UK has a large and thriving life… Read More

#News

Great British Pounds, Investment
#ABPI #Life sciences #UK budget #UK economy #UK government

UK Chancellor backs life sciences in the Budget

The UK’s Labour Government has announced its first budget, which focuses on stability, investment, and long-term growth. Key announcements in the Budget included increases in NHS funding, a £520m life sciences innovative manufacturing fund, and investment in research and development, including increased funding for the National… Read More

#News #Trending News

Antibiotics
#ABPI #Antibiotics #Antimicrobial resistance (AMR) #Antivirals #United Nations #WHO

Access to medicines vital in tackling AMR, world leaders agree

Global leaders have approved a plan to reduce the estimated 4.95 million human deaths associated with bacterial antimicrobial resistance (AMR) annually by 10% by 2030. The political declaration was agreed at the 79th United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance (AMR). Read More

#News #Trending News

Image of the earth showing the UK and Scandinavia
#ABPI #Drug discovery #Investment #Life sciences #Medicines Discovery Catapult (MDC)

Why the UK needs to nurture a fit-to-fund life sciences sector 

Professor Chris Molloy, CEO of Medicines Discovery Catapult (MDC), writes about the state of the UK’s drug discovery sector, exploring economic challenges and what is needed to support the country’s rich life sciences talent.   We should all be proud of and inspired by the UK life sciences sector’s rich… Read More

#Exclusive Content

#ABPI #Marketing approval authorisation #MHRA #Regulatory #UK

New UK authorisation policy draws on international drug approvals

The UK Medicines and Healthcare products Regulatory Agency’s (MHRA) new International Recognition procedure (IRP) will allow it to draw on the expertise of regulators in other countries when authorising medicines. The MHRA will retain ultimate authority to accept or reject applications submitted under the IRP, but it is hoped that… Read More

#News #Regulatory

#ABPI #Association of the British Pharmaceutical Industry #Pharmaceutical industry #UK #UK government

Industry rejects ‘damaging’ changes to UK medicines scheme

Over twenty pharma companies have rejected the UK government’s proposed changes to the statutory scheme for branded medicines, the latest move in an ongoing disagreement between the government and industry. According to the Association of the British Pharmaceutical industry (ABPI), the “radical plans” are “unworkable”. And… Read More

#News

EU flag
#ABPI #Cancer Research UK #EU #Horizon Europe #Life sciences #UK government

UK joins Horizon Europe in “huge win” for research community

Following lengthy negotiations, the UK government has announced that the UK will be participating as a fully associated member of Horizon Europe for the remaining life of the programme to 2027. UK researchers can now apply for grants and bid to take part in projects under… Read More

#News #Trending News

#ABPI #Big pharma #Biopharma #Covid-19 #Ipsos #UK

Pharma maintains high level of trust from UK public and doctors

The pharmaceutical industry continues to maintain strong levels of public trust and favourability in the UK, according to data from the Association of the British Pharmaceutical Industry (ABPI). Opinions showed consistent recognition of the sector’s support for the NHS, with 67% of respondents saying the industry… Read More

#News